SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-159718
Filing Date
2012-04-12
Accepted
2012-04-12 06:06:45
Documents
5
Period of Report
2012-05-15
Effectiveness Date
2012-04-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d326402ddef14a.htm DEF 14A 966412
2 GRAPHIC g326402g20f99.jpg GRAPHIC 3873
3 GRAPHIC g326402g34p54.jpg GRAPHIC 29521
4 GRAPHIC g326402g38r75.jpg GRAPHIC 8969
5 GRAPHIC g326402g90g11.jpg GRAPHIC 4934
  Complete submission text file 0001193125-12-159718.txt   1033236
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19700 | Film No.: 12755386
SIC: 2834 Pharmaceutical Preparations